
Lupin Limited has informed the Exchange regarding a press release dated February 10, 2025, titled "Lupin Receives Approval from U.S. FDA for Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03%".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated February 10, 2025, titled "Lupin Receives Approval from U.S. FDA for Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03%".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin